During the past decade, Instituto Jalisciense de Cancerología conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Jalisciense de Cancerología" #1 collaborator was "University of Guadalajara" with 2 trials as a collaborator and "Instituto Mexicano del Seguro Social" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Jalisciense de Cancerología" are "Breast Cancer" (1 trials), "Endocrine Therapy" (1 trials), "Endocrine Therapy Adverse Reaction" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Nutrition Disorders" (1 trials). Many other conditions were trialed in "Instituto Jalisciense de Cancerología" in a lesser frequency.

Most popular intervention types in "Instituto Jalisciense de Cancerología" are "Diagnostic Test" (1 trials), "Drug" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anastrozole" (1 trials), "Basal" (1 trials), "Exemestane" (1 trials), "Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes." (1 trials) and "Recurrence" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Jalisciense de Cancerología" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Instituto Jalisciense de Cancerología". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Instituto Jalisciense de Cancerología, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Jalisciense de Cancerología, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".